Karyopharm to Present Selinexor Data at the 66th American Society of Hematology Annual Meeting and Exposition
Provided By PR Newswire
Last update: Nov 18, 2024
NEWTON, Mass., Nov. 18, 2024 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced abstracts detailing selinexor data have been selected to be presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being held December 7-10, 2024 in San Diego, CA.
Read more at prnewswire.com
